Yunda Huang

18PUBLICATIONS
99CO-AUTHORS
Genetic immunologyInnate immunityNanomedicineImmunogenetics (incl. genetic immunology)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|Oct 06, 2025
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.

Nonhlanhla N Mkhize, Bo Zhang, Caroline Brackett

|Jul 05, 2025
Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials.

Yunda Huang, Bo Zhang, Lily Zhang

|Jun 09, 2025
Pharmacokinetics Analysis of Serum and Rectal Tissue Concentrations of a Pair of Anti-HIV Monoclonal Antibodies, VRC01 and VRC01LS, in Adults Without HIV.

Yunda Huang, Lily Zhang, Maria P Lemos

|Nov 28, 2024
Enhanced and sustained biodistribution of HIV-1 neutralizing antibody VRC01LS in human genital and rectal mucosa.

Maria P Lemos, Rena D Astronomo, Yunda Huang

|Mar 23, 2024
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.

Daniel B Reeves, Bryan T Mayer, Allan C deCamp

Pageof 3

Frequent Collaborators

11 joint publications

Lawrence Corey

10 joint publications

Lindsay N Carpp

10 joint publications

Peter B Gilbert

7 joint publications

Michal Juraska